Bnp Paribas Arbitrage, Snc »

Serina Therapeutics shares owned by Bnp Paribas Arbitrage, Snc

Quarter-by-quarter ownership of Serina Therapeutics shares owned by Bnp Paribas Arbitrage, Snc from 13F filings

Historical chart of Bnp Paribas Arbitrage, Snc investment in Serina Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Serina Therapeutics held by Bnp Paribas Arbitrage, Snc consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Serina Therapeutics by Bnp Paribas Arbitrage, Snc

Quarter filed Position value Share count Share price at filing
2024-03-31 $27 2 13.50

More positions owned by Bnp Paribas Arbitrage, Snc

Microsoft Corp Equity (MSFT)
Apple Equity (AAPL)
NVIDIA Corp Equity (NVDA)
Meta Platforms Equity (META)
Amazon.com Equity (AMZN)
Tesla Equity (TSLA)
Broadcom Equity (AVGO)
Alphabet Equity (GOOGL)
Advanced Micro Devices Equity (AMD)
Industrial Select Sector SPDR Fund Fund (XLI)
Exxon Mobil Corp Equity (XOM)
iShares Russell 2000 ETF Fund (IWM)
Visa Equity (V)
JPMorgan Chase & Co Equity (JPM)
Alphabet Equity (GOOG)

View all positions for Bnp Paribas Arbitrage, Snc

Top funds holding Serina Therapeutics

Vanguard Group
BlackRock
Citigroup
Tower Research Capital
Wells Fargo & Company
Riggs Asset Managment
Morgan Stanley
Albion Financial Group
Advisor Group Holdings
UBS Group
Bnp Paribas Arbitrage, Snc
Jpmorgan Chase & Co

View all funds holding Serina Therapeutics